Refractory Acute Lymphoblastic Leukemia Terminated Phase Trials for Sirolimus (DB00877)

Also known as: Acute Lymphoblastic Leukemia, Refractory / Acute, refractory Lymphoblastic Leukemia / Acute, refractory Lymphocytic leukaemia / Acute, refractory Lymphocytic Leukemia / Acute lymphocytic leukemia refractory / Acute, refractory Lymphoblastic Leukaemia / Acute lymphocytic leukaemia refractory / Refractory Acute lymphoblastic leukaemia

IndicationStatusPhase
DBCOND0058624 (Refractory Acute Lymphoblastic Leukemia)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01658007Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/LymphomaTreatment